Medtech Money
By Project Medtech
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Project Medtech
Category: Investing
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 129
Description
The Medtech Money Podcast produced by Project Medtech is a podcast series focused on demystifying raising and investing capital for Medtech startups. There will no longer be new episodes of Medtech Money. Head over to the Project Medtech Podcast for more great content.
| Episode | Date |
|---|---|
|
Episode 129 | Rich Mazzola, CFO at Project Medtech | Introducing the New Host of the Funding Medtech Podcast powered by Project Medtech
|
Oct 04, 2023 |
|
Episode 128 | Giovanni Lauricella, Co-Founder and Managing Partner at Lifeblood Capital | A Recap of Giovanni's Time as Host of the Medtech Money Podcast powered by Project Medtech
|
Sep 27, 2023 |
|
Episode 127: Hanson Gifford, Managing Partner of The Foundry & Partner at Lightstone Ventures | Living Legend: Medtech Money Demystified with a Serial Entrepreneur and Venture Capitalist
|
Jun 21, 2023 |
|
Episode 126: Eric Goslau, President & CEO at Transverse Medical | Raising Series B: The Hard Things About HardTech and Being an Entrepreneur
|
Jun 14, 2023 |
|
Episode 125: Steven Pacelli, Executive Vice President and Managing Director of Dexcom Ventures | $100M Fund: The Story of Dexcom Ventures and Corporate Venture Capital
|
Jun 07, 2023 |
|
Episode 124: Greg Walters, Founder & CEO of Excision Medical | First-Time Founder Gets An Exit and Starts Startup #2: What It Takes and What To Expect From Achieving an Acquisition
|
May 31, 2023 |
|
Episode 123: Chris Bostick, Partner at Orchard Capital Ventures | $175M AUM: Investing with Patients, Providers and Payers in Mind & Breaking Down Why Fundraising is More Challenging Now
|
May 24, 2023 |
|
Episode 122: Austin Sawyer, Associate at Nina Capital | From Entrepreneur to Venture Capitalist: Breaking Down the Nuances
|
May 17, 2023 |
|
Episode 121: Scott Nelson, Co-Founder and CEO of FastWave Medical | Raising Series B After Skipping a Seed Round and Closing a Series A with a Chinese Strategic
|
May 10, 2023 |
|
Episode 120: Josh Seidenfeld, Partner at Cooley LLP | Mitigating Mistakes: Legal Strategies for Raising Capital and Building Medtech Startups
|
May 03, 2023 |
|
Episode 119: Laura Indolfi, Founder & CEO of PanTher Therapeutics | $14.2M Grant: TED Fellow Goes to Austin from Boston after Seed, Series A, and CPRIT Grant
|
Apr 28, 2023 |
|
Episode 118: Amar Sawhney, General Partner of Incept & CEO of Instylla and Rejoni | Brains, Sweat and Money: Self-Funding and Raising Capital for 25 Startups
|
Apr 26, 2023 |
|
Episode 117: Liridon Rrushaj, Director of Venture Investing at OSF Ventures | $250M AUM: Understanding Health System Investment Arms as an Alternative to Venture Capital
|
Apr 19, 2023 |
|
Episode 116: William Dai, Founding Managing Partner of ShangBay Capital | 4th Fund: Ranked “The Most Active Medical Device Venture Capital Firm” 3 Years in a Row By SVB
|
Apr 12, 2023 |
|
Episode 115: Patrik Schmidle, Founder & CEO at CARI Health | $2.3M Seed Round: A Full Year of Raising from Angels Down to the Wire of December 31st
|
Apr 06, 2023 |
|
Episode 114: Michael Wallace, Founder & CEO of Devoro Medical | $336M Acquisition: Raising for Build-to-Buy Exits, Apprentice Phenomena & Venture Partners
|
Mar 22, 2023 |
|
Episode 113: Ted Bird, Chief Strategy Officer at Dymicron | Crowdfunding for Medtech: The Other Alternative Source of Capital
|
Mar 15, 2023 |
|
Episode 112: Surbhi Sarna, Group Partner at Y Combinator and Author of "Without A Doubt" | $275M Acquisition: Without A Doubt, A Medtech Entrepreneurial Story for a Book
|
Mar 07, 2023 |
|
Episode 111: Philippe Pouletty, Founder & CEO at Truffle Capital | €250M Fund and More: Business Builders for Radical Innovation
|
Mar 01, 2023 |
|
Episode 110: Abby Hunter-Syed, Director, Olympus Innovation Ventures | $50M Fund: Corporate Venture Capital vs. Institutional Venture Capital & How to Pitch Investors
|
Feb 22, 2023 |
|
Episode 109: Jenny Regan, Founder at Key Tech | ESOP: Succession Planning and Exiting for MedTech Service Providers
|
Feb 15, 2023 |
|
Episode 108: Jay Goss, General Partner at Wavemaker Three-Sixty Health |$64M Fund 2: Serial Entrepreneur Turns Early-Stage VC & Health Tech vs. MedTech
|
Feb 01, 2023 |
|
Episode 107: Julia Prakapovich, Partner at Interface Fund | $20M First Fund: DeepTech Definition and the Humanness of Venture Capital
|
Jan 25, 2023 |
|
Episode 106: Stephen Towe, CEO at Leo Cancer Care | $55M Raised: From Physicist to Entrepreneur & Creating a Diversified Investor Strategy of Strategics and VCs
|
Jan 18, 2023 |
|
Episode 105: Bruce Lichorowic, President & CEO at Galen Robotics | $15M Series A: Angels, Family Offices, VCs and State Government Incentive Programs? The move from High-Tech to MedTech
|
Jan 11, 2023 |
|
Episode 104: Ronit Harpaz, Co-founder & CEO at Endoron Medical | $5M Seed Extension to Series A: Female Israeli Serial MedTech Entrepreneur’s Psychology on Capital
|
Dec 07, 2022 |
|
Episode 103: Joe Rafferty, CEO at VESTECK, Inc. | $6M Series A + $4M Extension: The Bridge from Angels to Venture Capitalists
|
Nov 30, 2022 |
|
Episode 102: Ramin Mousavi, President, CEO, & Board of Directors at CathWorks | $75M & Acquisition Agreement with Medtronic: The Art of the Cathworks Deal That Led to a One-of-a-Kind $585M Partnership
|
Nov 23, 2022 |
|
Episode 101: Shamik Parekh, Healthtech Investor at Octopus Ventures | £1.7 Billion AUM and £200 Million Invested per Year: Pan-European & UK Early-Stage Digital and HealthTech Investor Demystifies Due
|
Nov 16, 2022 |
|
Episode 100: Bryan Chambers, Co-Founder and CEO at Capital Factory | Capital Factory’s Impact on Innovation – There Is Nothing Like It: The Third Coast, The Texas Fund, The Texas Manifesto, & Texas Ne
|
Sep 22, 2022 |
|
Episode 99: Connor Glass, Founder at Phantom | $6M Seed-1 Round: Unconventional Everything & Physician-Entrepreneur raises first capital from VCs for Human-Machine Interfaces
|
Sep 21, 2022 |
|
Episode 98: Alberto Rodriguez-Navarro, President and CEO of Levita Magnetics | $26M Series C: Surgical Robotics, Latin America, Magnets, Physician-Entrepreneur & Angels vs. VCs
|
Sep 21, 2022 |
|
Episode 97: Fady Saad, General Partner at Cybernetix Ventures | $50M First Fund: Starting a Venture Capital Firm – Philosophy, MassRobotics & Complex System
|
Sep 21, 2022 |
|
Episode 96: Farzad Soleimani, Healthcare Partner at 1984 Ventures | $75M 2nd Fund: Physician-Venture Capitalist – Software, SAFEs, Angels & Texas Innovation
|
Sep 20, 2022 |
|
Episode 95: Sidney Collin, CEO & Co-Founder at De Oro Devices | $4.5M Seed Rounds for Class I Medtech: Startup Founder Raised $500K Before Graduating College & The Difference Between Angels and VCs
|
Sep 19, 2022 |
|
Episode 94: Darshana Zaveri, Managing Partner at Catalyst Health Ventures | 3rd Fund: Dedicated to Medical Devices & VC Insight into Passion, LPs, and Investing Through Recession
|
Sep 16, 2022 |
|
Episode 93: Yotam Drechsler, CEO and Co-Founder at BrainQ Technologies | $50+ Million To-Date: An Israeli Medtech Entrepreneur’s Perspective on Raising Capital
|
Sep 16, 2022 |
|
Episode 92: Michael Monovoukas, CEO and Co-Founder at AcuityMD | $31M Series A: The Three Ms – “Milestones, Metrics and Multiples” & Raising From a Position of Strength
|
Sep 08, 2022 |
|
Episode 91: Andrew Glass, Chief Executive Officer at Vivasure Medical | Up to €52M Series D: Corporate Venture Capitalist Turns to Entrepreneurship & Insight on Raising Capital from US, EU and China
|
Sep 06, 2022 |
|
Episode 90: David Kereiakes, Partner at Providence Ventures | Alternative Capital with Healthcare System Venture Arms: Adding Value Beyond Capital and Motives for Overcoming the McKinsey Report
|
Sep 01, 2022 |
|
Episode 89: Frederik Groenewegen, Co-Founder & General Partner @ 415 Capital | €75M Fund: Building an Early-Stage VC Firm with a Love for Cardio, Neuro, and Robotics
|
Aug 24, 2022 |
|
Episode 88: Dave Marver, CEO at Onward | $95M IPO: Mechanics on Taking a Medtech Startup Public in Europe vs. USA
|
Aug 17, 2022 |
|
Episode 87: Jonathan Ng, CEO at Iterative Scopes | $150M Series B: Philosophy, Philanthropy, Privilege & North Stars --- Two Minutes of Fame for Months and Years of Hard Work
|
Aug 10, 2022 |
|
Episode 86: Amy Kruse, General Partner at Prime Movers Lab | $1+ Billion AUM: From Founder to Funder in Early-Stage DeepTech -- Dilution, Pitch Decks & Human Augmentation
|
Aug 03, 2022 |
|
Episode 85: Louis Cannon, Founder & Senior Managing Director at BioStar Capital | $175M 5th Fund: Demystifying the Physician-Venture Capitalist, How to Start a VC Firm & Valuations for Pre-Revenue
|
Jul 27, 2022 |
|
Episode 84: Bart Sanders, CEO & Co-Founder at Stentit B.V. | €1.8M Seed: Engineer Turned First-Time Entrepreneur Shares "The Grind" of Raising the First External INvestor Capital & The Magic of Eindho
|
Jul 20, 2022 |
|
Episode 83: Brian Fahey, President and CEO at Adona Medical | $39.25M Series B for Class III Medtech: A Shifamed Startup Story & Tactical Insights on Raising Capital from a Serial Entrepreneur
|
Jul 13, 2022 |
|
Episode 82: Dan Lemaitre, Chairman & CEO BlueWind Medical | $64M Series B: How a Medtech Living Legend Builds a Story of Linear Milestones to Raise Capital & Over the Rainbow from Israel to Utah
|
Jul 06, 2022 |
|
Episode 81: Daniel Powell, CEO at Spark Biomedical | $10M Series A: The Shift from Raising Capital from Angels to VCs --- Forgiving to Unforgiving and Why Entrepreneurs Need to Know Their Business
|
Jun 29, 2022 |
|
Episode 80: Dan Gelvan, CEO at t-syte Ltd | Family Office Insights: The Secrets of Silent Capital, Israel & How Added-Value Turns Into a Venture Lab
|
Jun 22, 2022 |
|
Episode 79: Sebastian Anastassiou, Investment Manager at Nina Capital | €62M, 3 Years, 2 Funds, 31 Portfolio Startups: Spanish Venture Capital & the Secret to Hyperfocus and Patterns
|
Jun 15, 2022 |
|
Episode 78: David Sylvan, President at University Hospitals Ventures | Why Hospitals are an Option for Capital: How Healthcare System Venture Arms Work and Their Added Value to Medtech
|
Jun 08, 2022 |
|
Episode 77: Sam Ifergan, Founder and Managing Partner at iGan Partners | Largest Canadian Medtech VC ($500M AUM): iGan Arabia Fund Launch & Insight on VC Investment Thesis Creation
|
Jun 01, 2022 |
|
Episode 76: Ruben Osnabrugge, Director/Investment Manager at EQT Life Sciences | The Physician VC: How, Why, and the Value-Add to Due Diligence & The Story of a VC Firm Joining Forces with a Large PE
|
May 25, 2022 |
|
Episode 75: JD Friedland, Partner, Cleveland Clinic Ventures | Cleveland Clinic (Ventures) Innovations: Inside-Out vs. Outside-In Approach & Investing Off the Balance Sheet Like Corporate VC
|
May 18, 2022 |
|
Episode 74: Mina Fahim, CEO at MediView | $9.9M or $10M SAFE Seed Round: From Engineer to Capital Raising Entrepreneur --- The Power of Social Media, Leadership & Storytelling
|
May 11, 2022 |
|
Episode 73: Tom Gerhardt, CEO at ReCross Cardio | $1.25 Million Seed Round: First-Time Founder Building a Startup and Raising Capital Between South Africa, U.S., Europe, and Israel
|
May 04, 2022 |
|
Episode 72: Keith Matheny, Serial Entrepreneur | Demystifying the Physician-Entrepreneur Stereotype: Venturing through Business 101 and Raising Capital to Bring Medtech Innovation to Patients
|
Apr 27, 2022 |
|
Episode 71: Daniel Adler, CEO & Co-Founder at BioT | $6.5 Million Seed Round: Israeli Medtech SaaS Startup Shares the Importance of Investor Diversity and Finding a Lead Investor
|
Apr 22, 2022 |
|
Episode 70: Tamir Meiri, Director, Venture Investments at Johnson & Johnson Innovation | J&J's Corporate Venture Arm: Full Range Investments from Company Formation to PIPEs Fueling the M&A Pipeline
|
Apr 20, 2022 |
|
Episode 69: Hamman de Vaal, Chief Commercial Officer at AdjuCor GmbH | €29 Million Series B: The Power of Investor FOMO & How Western Startups Can Raise Capital from China using Investment Bankers ---
|
Apr 15, 2022 |
|
Episode 68: Catello Somma, Associate at TVM Life Sciences | $478 Million Growth Fund: What Entrepreneurs Don't Known about How Investors Conduct Due Diligence on Startups & How to Build a Pitch Deck
|
Apr 13, 2022 |
|
Episode 67: Catherine Boule, Managing Partner at Karista | Why Digital Health is Different: European, Early-Stage, Digital Health Fund Invests on the Future for Medtech and Healthtech Converging
|
Apr 08, 2022 |
|
Episode 66: Graeme Smith, CEO at Lightpoint Medical | Equity and Debt Series C-2: Common Shares for All Investors & Hired CEO for Confidence, Commercialization, and Sustainability
|
Apr 06, 2022 |
|
Episode 65: Andreas Forsland, Founder & CEO at Cognixion | $12 Million Seed Round: The Convergence of Medtech, DeepTech, and ConsumerTech
|
Apr 01, 2022 |
|
Episode 64: Renee Ryan, CEO at Cala Health | Raising $77 Million as a First-Time CEO: How an Investment Banker became a Corporate Venture Investor who turned to Entrepreneurship
|
Mar 30, 2022 |
|
Episode 63: David Suendermann-Oeft, Co-Founder & CEO at Modality.AI | Raising Capital for SaMD: Team, Accelerators, Global Investor Syndicates, Delaware C-Corps, and Importance of "Investor Fit"
|
Mar 26, 2022 |
|
Episode 62: Soumya Mahapatra, Co-Founder & CEO at Essenvia | Medtech SaaS, Startups, and SAFEs: How a First-Time Entrepreneur Raised a $1.4 million Seed Round in Two Weeks
|
Mar 23, 2022 |
|
Episode 61: Manuel Opitz, Co-Founder & CEO at Deepeye GmbH | Software vs. Hardware and the Two-Way Street: How CEOs Save Time Raising Capital By Doing Due Diligence on Investors
|
Mar 19, 2022 |
|
Episode 60: Antoine Papiernik, Chairman & Managing Partner at Sofinnova Partners | Think Big with "What if They Are Right?": Love for Medtech and Sofinnova's 50th Anniversary with €2,5 Billion AUM
|
Mar 16, 2022 |
|
Episode 59: Luca Ravagnan, CEO and Co-Founder at WISE Srl | $20 Million Series C: The Semi-Full Entrepreneurial Story of a Researcher to Founder to Product Commercialization
|
Mar 09, 2022 |
|
Episode 58: Fionn Lahart, Co-Founder and CEO at OneProjects --- Raising Series A of $29 Million: The Story of Bioinnovate, Co-located Co-Founders, Venture/Grant Funding and Skipping the Seed Stage
|
Mar 02, 2022 |
|
Episode 57: Robert Hamilton, Co-Founder, Chief Scientific Officer at NovaSignal Corp --- $37 Million Series C: Co-Founder Shares Business Lessons from R&D to Commercialization
|
Feb 23, 2022 |
|
Episode 56: Todd Usen, CEO at Activ Surgical --- First Time CEO Raises $72 million in 2.5 Years: Team, Tech & Fundamentals with a Slice of Humble Pie
|
Feb 16, 2022 |
|
Episode 55: James Eadie, Managing Director at Sante --- Military Physician Turns Early-Stage Venture Capitalist: A People's Game, Love the Truth, and Be Smart about Valuations
|
Feb 09, 2022 |
|
Episode 54: Peter Vranes, Co-CEO at Nutromics --- Medtech Innovator Finalist from Australia Raises $4 Million: Entrepreneurship Under a Glass Ceiling and a Focus on the US
|
Feb 02, 2022 |
|
Episode 53: Cristiano Fontana, CEO at Three Bridge M&C --- Entrepreneur Turned Facilitator: Demystifying Pre-Money Valuation and Early-Stage Licensing Deals
|
Jan 26, 2022 |
|
Episode 52: Janelle Goulard, Partner at Pangaea Ventures --- Early-Growth Venture Capital: Insight into VC Life --- the Mechanics of How VCs Think and Structure their Firms
|
Jan 19, 2022 |
|
Episode 51: Daniel Hawkins, CEO at Avail Medsystems --- $100 Million Series B: One of Medtech's Living Legends
|
Jan 12, 2022 |
|
Episode 50: Ahmed Zobi, CEO at Syntr Health Technologies --- Entrepreneurship: Startup Founder who Raised Capital and Achieved FDA Clearance after Bachelor's Degree
|
Jan 01, 2022 |
|
Episode 49: Eyal Lifschitz, Co-Founder and General Managing Partner at Peregrine Ventures --- The First Dedicated Medtech Venture Fund in Israel: The Story of "Startup Nation"
|
Dec 31, 2021 |
|
Episode 48: Juan Arango, Executive Director at Keiretsu Forum --- Providing Access to Early-Stage Capital and Value-Added Resources for Medtech Startups
|
Dec 30, 2021 |
|
Episode 47: Emily Caporello, Director at NINDS and David McMullen, Program Chief at NIMH --- NIH Insights: Grants, Non-Dilutive Funding, and The Blueprint Program --- Demystified
|
Dec 17, 2021 |
|
Episode 46: Gautam Kainth, Managing Director at the Capital Partnership --- UK Venture Capital Firm Makes US Investments: Global Trends and Perspectives
|
Dec 15, 2021 |
|
Episode 45: Anne Osdoit, Partner at Sofinnova Partners and MD Start, CEO at Moon Surgical --- Entrepreneur and Venture Capitalist at the Same Time: A Medtech Powerhouse
|
Dec 08, 2021 |
|
Episode 44: Sascha Alilovic, Managing Partner at SHS --- Growth Capital Focused on DACH: European Late-Stage Venture Perspective
|
Dec 03, 2021 |
|
Episode 43: Juan Cueva, Investor at Action Potential Venture Capital --- Big Pharma Creates an Early Stage Corporate Venture Medtech Fund: The Mission of Bioelectronics
|
Dec 01, 2021 |
|
Episode 42: James Biggins, CEO at Access Vascular --- Founder Raises Series B: R&D to Commercialization --- The Full Spectrum of Medtech
|
Nov 24, 2021 |
|
Episode 41: Yoav Fisher, Head Of Technological Innovation and Digital Health at HealthIL --- Israel's Healthcare Innovation Ecosystem that Facilitates Startups' Investability
|
Nov 19, 2021 |
|
Episode 40: Oliver Keown, Director at Intuitive Ventures --- The $100 Million Fund: The Role and Purpose of Corporate Venture Capital
|
Nov 17, 2021 |
|
Episode 39: Lucian Goffart, CEO at Robocath --- How Western Medtech Startups Raise Capital from China: The Value of Investment Bankers
|
Nov 12, 2021 |
|
Episode 38: Thom Rasche, Managing Partner at Earlybird Venture Capital --- Seed, Series A & Series B: Venture Capital for Europe, by Europe --- with a Unique Limited Partner
|
Nov 10, 2021 |
|
Episode 37: John Gillings, Vice President at Accelmed --- What is Private Equity: The Differences between Price Equity and Venture Capital
|
Nov 05, 2021 |
|
Episode 36: Zied Tayeb, Founder of Myelin-H --- Raising Early-Stage Capital: The Story's Power when the Founder is Personally Connected to the Technology
|
Nov 03, 2021 |
|
Episode 35: Howard Walthall, Co-Founder & CEO of Lumiheal Therapeutics --- Lawyer Turned Entrepreneur Raising Capital Early-Stage Capital: Where to Begin?
|
Oct 29, 2021 |
|
Episode 34: Kelly Roman, Co-Founder & CEO of Fisher Wallace Laboratories --- Alternative Capital: How to Raise Capital Using Crowdfunding for a Medtech Startup
|
Oct 27, 2021 |
|
Episode 33: Howard Edelman, CEO at Tesa Medical and Life Science Angel --- West Coast Angel Group: Similarities and Differences from Midwest and East Coast Angel Groups
|
Oct 22, 2021 |
|
Episode 32: Olivier Litzka, Partner at Andera Partners --- The Power of And: Investing in Early and Late-Stage Global Medtech Startups --- European Perspective
|
Oct 20, 2021 |
|
Episode 31: Charlie Huiner, CEO at Modulim --- Being Hired as CEO to Raise Capital for US Commercialization: Where to Begin?
|
Oct 14, 2021 |
|
Episode 30: Jennifer McMahon, Principal at Seroba Life Sciences --- Women in Medtech Venture Capital & How Early-Stage European VCs Invest
|
Oct 12, 2021 |
|
Episode 29: Gaston Vasseur, Investment Manager at Anaxago --- Insight into Early-Stage Medtech and Digital Health Venture Capital in France
|
Oct 08, 2021 |
|
Episode 28: Tracy MacNeal, CEO of Materna Medical --- Women's Health CEO Raises Series A: Advancement in Femtech
|
Oct 06, 2021 |
|
Episode 27: Thomas Busby, Vice President of Healthcare & Life Science Investment Banking at Outcome Capital --- Investment Banker's Insight: Raising Capital, M&A, and U.S. Market Dynamics in the Medte
|
Oct 01, 2021 |
|
Episode 26: Paul Grand, CEO of Medtech Innovator --- How the World's #1 medtech Accelerator Prepares Its Start-Ups for External Capital and Growth
|
Sep 29, 2021 |
|
Episode 25: Florian Ludwig, Healthcare Investor at Thuja Capital --- Transitioning from Medtech Industry to Venture Capital and How Venture Capital Works in BENELUX
|
Sep 24, 2021 |
|
Episode 24: Tom Shehab, Managing Partner at Arboretum Ventures --- The Business Experienced Physician VC who Ventures into Under-Ventured Medtech Geographies: The Midwest and Beyond
|
Sep 22, 2021 |
|
Episode 23: Michael Moore, CEO at Pathware --- Leaving Medical School , Starting a StartUp, and Doing Whatever It Takes to Raise Capital: The Journey of Grit
|
Sep 17, 2021 |
|
Episode 22: Simon Sonntag, CEO at Virtonomy --- European First-Time CEO raises Seed Capital for Medtech SaaS: Money Heist?
|
Sep 15, 2021 |
|
Episode 21: Reinhard Krickl, CEO at Phagenesis --- Europe: First-Time CEO Raising Capital for Commercialization
|
Sep 10, 2021 |
|
Episode 20: Jeroen Siemes, Senior Investment Manager at BOM Brabant Ventures --- How Medech Venture Capital works under a Provincial Focus --- Brabant, Netherlands
|
Sep 08, 2021 |
|
Episode 19: Casey McGlynn, Partner at Wilson Sonsini Goodrich & Rosati --- How and When to use an Attorney for Raising Capital as a Medtech Start-up
|
Sep 03, 2021 |
|
Episode 18: Anish Kaushal, Investment Analyst at Amplitude Venture --- How Venture Capital Works in Canada
|
Sep 01, 2021 |
|
Episode 17: Alessio Beverina, General Partner at Panakes Partners --- Early-Stage Capital in Europe and Raising a €150 Million Second Investment Fund
|
Aug 27, 2021 |
|
Episode 16: Gur Roshwalb, Partner at aMoon --- Israeli Medtech Venture Capital Firm Invests in Both Early and Late-Stage Moon Shots
|
Aug 25, 2021 |
|
Episode 15: Chris DuPont, CEO at Galen Data --- Raising Series A for Medtech SaaS
|
Aug 20, 2021 |
|
Episode 14: Marc Zemel, CEO at Retia Medical and Digitouch Health --- Leading and Raising Capital for Two Medtech Startups at the Same Time, with Different Strategies
|
Aug 18, 2021 |
|
Episode 13: Ash Attia, CEO at Bionic Vision Technologies --- What is it like to Raise Capital for a Medtech Startup in Australia --- An Aussie Entrepreneur's Perspective
|
Aug 13, 2021 |
|
Episode 12: Orrin Ailloni-Charas, CEO, Managing Partner at Global Health Impact Fund --- What is a Micro VC and What are the Benefits of Physician Investors for Early Stage Start-ups
|
Aug 11, 2021 |
|
Episode 11: Yaniv Sneor, Founder at MABA --- U.S. Angel Groups --- The Hard Truth of Their Investment Approach and Why They Differ
|
Aug 06, 2021 |
|
Episode 10: Michael Nagel, President & CEO at Vomaris Innovations --- A U.S. CEO's Perspective of Raising Capital from Family Offices --- The Good, the Bad, and Why it is an Alternative to a VC
|
Aug 04, 2021 |
|
Episode 9: Alexandra MacLean, Partner at TVM Capital Life Science --- From Physician to Industry Professional to Venture Capitalist --- The Career Path and Credibility of a Medtech VC
|
Jul 30, 2021 |
|
Episode 8: Eric Heinz, Director, Business Development (M&A) at Smith & Nephew --- How Corporate Strategics Assess Medtech Start-Ups for Investment
|
Jul 28, 2021 |
|
Episode 7: Geoff Pardo, Partner at Gilde Healthcare --- Insights from a Transatlantic Late-Stage Venture Capital Firm - How to Invest in Both Europe and the U.S.A.
|
Jul 23, 2021 |
|
Episode 6: Jeff Rynbrandt, President & CEO at MediCool Technologies --- Stories About Raising Money from a First Time CEO
|
Jul 21, 2021 |
|
Episode 5: Olivier d'Arros, Managing Partner at MAVIE --- What the World Needs to Know About Raising Capital from China
|
Jul 16, 2021 |
|
Episode 4: Bryce Klontz, CEO at New View Surgical --- First-Time CEO in U.S. Explains Raising Capital from Angel Groups
|
Jul 14, 2021 |
|
Episode 3: Carl Stamp, Gopher Angels --- A Fireside Chat with an Angel Investor
|
Jul 07, 2021 |
|
Episode 2: Carlo Stimamiglio, Partner at Alira Health --- How and When a Medtech Start-Up Should Partner with an Investment Banker
|
Jun 30, 2021 |
|
Episode 1: Brian Greene, CTO at HMD Labs --- Leaving Corporate to become a Medtech Founder
|
Jun 21, 2021 |